Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

102 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Methylated NEUROD1 promoter is a marker for chemosensitivity in breast cancer.
Fiegl H, Jones A, Hauser-Kronberger C, Hutarew G, Reitsamer R, Jones RL, Dowsett M, Mueller-Holzner E, Windbichler G, Daxenbichler G, Goebel G, Ensinger C, Jacobs I, Widschwendter M. Fiegl H, et al. Clin Cancer Res. 2008 Jun 1;14(11):3494-502. doi: 10.1158/1078-0432.CCR-07-4557. Clin Cancer Res. 2008. PMID: 18519782 Free article.
HOXA methylation in normal endometrium from premenopausal women is associated with the presence of ovarian cancer: a proof of principle study.
Widschwendter M, Apostolidou S, Jones AA, Fourkala EO, Arora R, Pearce CL, Frasco MA, Ayhan A, Zikan M, Cibula D, Iyibozkurt CA, Yavuz E, Hauser-Kronberger C, Dubeau L, Menon U, Jacobs IJ. Widschwendter M, et al. Int J Cancer. 2009 Nov 1;125(9):2214-8. doi: 10.1002/ijc.24599. Int J Cancer. 2009. PMID: 19621443 Free article.
Hsa-miR-375 is a predictor of local control in early stage breast cancer.
Zehentmayr F, Hauser-Kronberger C, Zellinger B, Hlubek F, Schuster C, Bodenhofer U, Fastner G, Deutschmann H, Steininger P, Reitsamer R, Fischer T, Sedlmayer F. Zehentmayr F, et al. Clin Epigenetics. 2016 Mar 8;8:28. doi: 10.1186/s13148-016-0198-1. eCollection 2016. Clin Epigenetics. 2016. PMID: 26962366 Free PMC article.
Radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer predicts recurrence-free survival but not pathologic complete response (pCR).
Gampenrieder SP, Peer A, Weismann C, Meissnitzer M, Rinnerthaler G, Webhofer J, Westphal T, Riedmann M, Meissnitzer T, Egger H, Klaassen Federspiel F, Reitsamer R, Hauser-Kronberger C, Stering K, Hergan K, Mlineritsch B, Greil R. Gampenrieder SP, et al. Among authors: hauser kronberger c. Breast Cancer Res. 2019 Jan 31;21(1):19. doi: 10.1186/s13058-018-1091-y. Breast Cancer Res. 2019. PMID: 30704493 Free PMC article.
Transferring MINDACT to Daily Routine: Implementation of the 70-Gene Signature in Luminal Early Breast Cancer - Results from a Prospective Registry of the Austrian Group Medical Tumor Therapy (AGMT).
Westphal T, Gampenrieder SP, Rinnerthaler G, Balic M, Posch F, Dandachi N, Hauser-Kronberger C, Reitsamer R, Sotlar K, Radl B, Suppan C, Stöger H, Greil R. Westphal T, et al. Among authors: hauser kronberger c. Breast Care (Basel). 2022 Feb;17(1):1-9. doi: 10.1159/000512467. Epub 2021 Mar 30. Breast Care (Basel). 2022. PMID: 35355702 Free PMC article.
DNA Methylation Signatures Predicting Bevacizumab Efficacy in Metastatic Breast Cancer.
Gampenrieder SP, Rinnerthaler G, Hackl H, Pulverer W, Weinhaeusel A, Ilic S, Hufnagl C, Hauser-Kronberger C, Egle A, Risch A, Greil R. Gampenrieder SP, et al. Among authors: hauser kronberger c. Theranostics. 2018 Mar 11;8(8):2278-2288. doi: 10.7150/thno.23544. eCollection 2018. Theranostics. 2018. PMID: 29721079 Free PMC article.
102 results